Our goal at Selliza is to revolutionize patient access. Everything we do is motivated by this, from our groundbreaking work in biosimilars to our success in generics reaching the market first.
Robust corporate governance, innovative sustainable operations, and a commitment to creating an exceptional work environment at Sandoz underpin our efforts to promote access.
Selliza is aware that the state of the climate and other events can affect our company, and that our operations can have an influence on the environment and people in both positive and bad ways. Selliza examines which ESG concerns are most likely to affect our stakeholders, company, and valuation. The materiality evaluation serves as a roadmap for our efforts as we build additional business strategies and ESG.
Strong healthcare systems and improved patient access are things we support. Additionally, by endorsing the Sustainable Development Goals (SDGs) of the UN, we are changing the game. The Sustainable Development Goals (SDGs) are an alliance aimed at mitigating poverty, enhancing health and education, decreasing inequality, promoting economic expansion, and addressing climate change.
Sustainable patterns of consumption and production are important for responsible consumption and production. At Selliza, we take environmental responsibility seriously. We reduce our carbon footprint, protect natural resources, manage water and waste resources responsibly, and encourage a more environmentally friendly supply chain.